https://www.astellasanswers.com/search-results2025-07-101.0https://www.astellasanswers.com/content/dam/astellasanswers/hcp/na/us/en/images/no-results-image-homepage.pnghttps://www.astellasanswers.com/content/dam/astellasanswers/hcp/na/us/en/images/no-results-image-homepage.pnghttps://www.astellasanswers.com/home2025-07-170.9https://www.astellasanswers.com/content/dam/astellasanswers/hcp/na/us/en/images/astellasanswer-us-en-home-banner-desktop.pnghttps://www.astellasanswers.com/content/dam/astellasanswers/hcp/na/us/en/images/astellasanswer-us-en-home-banner-mobile.pnghttps://www.astellasanswers.com/content/dam/astellasanswers/hcp/na/us/en/images/astellasanswer-us-en-home-banner-mobile.pnghttps://www.astellasanswers.com/contact-us2025-04-070.9https://www.astellasanswers.com/resources2025-04-030.9https://www.astellasanswers.com/content/dam/astellaselement/astellasanswers/resource/Grant_Management.jpghttps://www.astellasanswers.com/content/dam/astellaselement/astellasanswers/resource/Clinical_Trials.jpghttps://www.astellasanswers.com/content/dam/astellaselement/astellasanswers/resource/Sponsored_Research.jpghttps://www.astellasanswers.com/content/dam/astellaselement/hcp/est/gb/en/images/Cards%252016%2520X%25209.pnghttps://www.astellasanswers.com/content/dam/astellaselement/astellasanswers/resource/R_D_Pipeline.jpghttps://www.astellasanswers.com/content/dam/astellaselement/astellasanswers/resource/SDS.jpghttps://www.astellasanswers.com/content/dam/astellaselement/astellasanswers/resource/Reimbursement.jpghttps://www.astellasanswers.com/submit-inquiry2025-04-030.9https://www.astellasanswers.com/find-my-msl2025-04-240.9https://www.astellasanswers.com/content/dam/astellasanswers/hcp/na/us/en/images/astellasanswer-us-en-find-my-msl-banner.pnghttps://www.astellasanswers.com/content/dam/astellasanswers/hcp/na/us/en/images/no-results-image-homepage.pnghttps://www.astellasanswers.com/content/dam/astellasanswers/hcp/na/us/en/images/profileplaceholder.jpeghttps://www.astellasanswers.com/articles2025-04-030.9https://www.astellasanswers.com/us/fezolinetant2025-04-030.9https://www.astellasanswers.com/us/fezolinetant/fezolinetant-and-history-of-cva-dvt-pe2025-07-280.9https://www.astellasanswers.com/us/fezolinetant/maximum-duration-of-fezolinetant-therapy2025-07-220.9https://www.astellasanswers.com/us/fezolinetant/fezolinetant-in-men2025-07-220.9https://www.astellasanswers.com/coming-soon2025-04-030.9https://www.astellasanswers.com/international-visitors2025-06-260.4https://www.astellasanswers.com/patient0.4https://www.astellasanswers.com/products2025-07-170.4https://www.astellasanswers.com/content/dam/astellasanswers/hcp/na/us/en/images/astellasanswer-hero-desktop-v3.pnghttps://www.astellasanswers.com/podcast2025-09-240.4https://www.astellasanswers.com/content/dam/astellasanswers/hcp/na/us/en/videos/astellasanswers-hcp-na-us-en-podcast-new.mp4https://www.astellasanswers.com/content/dam/astellasanswers/hcp/na/us/en/images/astellasanswer-us-en-podcast-matthew-strickland.pnghttps://www.astellasanswers.com/content/dam/astellasanswers/hcp/na/us/en/images/astellasanswer-us-en-podcast-leslie-swanson.pnghttps://www.astellasanswers.com/us/zolbetuximab0.3https://www.astellasanswers.com/us/avacincaptad-pegol0.3https://www.astellasanswers.com/patient/contact-us2025-06-190.3https://www.astellasanswers.com/patient/submit-inquiry2025-06-190.3https://www.astellasanswers.com/us/fezolinetant/restarting-fezolinetant-after-transaminase-elevation12342025-07-280.2https://www.astellasanswers.com/us/fezolinetant/fezolinetant-in-women-under-402025-09-100.2https://www.astellasanswers.com/us/fezolinetant/duration-of-fezolinetant-therapy2025-10-150.2https://www.astellasanswers.com/us/fezolinetant/fezolinetant-in-treatment-induced-vms2025-10-200.2https://www.astellasanswers.com/us/fezolinetant/fezolinetant-and-washout-periods-for-hormone-therapy2025-10-200.2https://www.astellasanswers.com/us/fezolinetant/fezolinetant-and-tamoxifen-serms-aromatase-inhibitors2025-10-200.2https://www.astellasanswers.com/us/fezolinetant/fezolinetant-and-history-of-dvt-pe-and-stroke2025-10-210.2https://www.astellasanswers.com/us/fezolinetant/fezolinetant-effect-on-sleep-global-sfr2025-10-230.2https://www.astellasanswers.com/us/fezolinetant/fezolinetant-in-women-over-652025-10-290.2https://www.astellasanswers.com/us/fezolinetant/fezolinetant-and-endometrial-assessment2025-11-130.2https://www.astellasanswers.com/us/fezolinetant/discontinuing-fezolinetant-in-patients-with-elevated-hepatic-transaminases2025-11-180.2https://www.astellasanswers.com/us/fezolinetant/fezolinetant-and-caffeine2025-11-180.2https://www.astellasanswers.com/us/fezolinetant/fezolinetant-adverse-events2025-11-180.2https://www.astellasanswers.com/us/fezolinetant/fezolinetant-and-examples-of-cyp1a2-inhibitors2025-11-180.2https://www.astellasanswers.com/us/fezolinetant/fezolinetant-and-hepatic-monitoring-requirements2025-11-180.2https://www.astellasanswers.com/us/fezolinetant/fezolinetant-and-hepatic-monitoring-after-1-year2025-11-190.2https://www.astellasanswers.com/us/fezolinetant/fezolinetant-in-cancer-patients2025-11-240.2https://www.astellasanswers.com/us/fezolinetant/fezolinetant-and-incidence-of-transaminase-elevation2025-11-260.2https://www.astellasanswers.com/us/fezolinetant/fezolinetant-and-patient-reported-quality-of-life-outcomes2025-11-260.2https://www.astellasanswers.com/us/fezolinetant/fezolinetant-and-rebound2025-11-260.2https://www.astellasanswers.com/us/fezolinetant/fezolinetant-and-the-endometrium2025-11-260.2https://www.astellasanswers.com/us/fezolinetant/fezolinetant-and-timing-of-transaminase-elevations2025-11-260.2https://www.astellasanswers.com/us/fezolinetant/fezolinetant-concomitant-use-with-ssri2025-11-260.2https://www.astellasanswers.com/us/fezolinetant/fezolinetant-moa-in-vms2025-12-110.2https://www.astellasanswers.com/us/fezolinetant/fezolinetant-with-ssri-and-snri-cyp1a2-inhibitors2025-12-110.2https://www.astellasanswers.com/us/fezolinetant/starting-or-restarting-fezolinetant-after-transaminase-elevation2025-12-110.2https://www.astellasanswers.com/us/fezolinetant/fezolinetant-drug-contraindications2025-12-120.2https://www.astellasanswers.com/us/fezolinetant/fezolinetant-drug-interactions2025-12-120.2https://www.astellasanswers.com/us/fezolinetant/fezolinetant-effect-on-sleep2025-09-040.2https://www.astellasanswers.com/us/fezolinetant/fezolinetant-effects-on-sex-hormones2025-12-120.2https://www.astellasanswers.com/us/fezolinetant/fezolinetant-in-premenopause-and-perimenopause2025-12-120.2https://www.astellasanswers.com/us/fezolinetant/post-marketing-hepatic-cases-with-fezolinetant2025-12-110.2https://www.astellasanswers.com/us/fezolinetant/fezolinetant-discontinuation-and-tapering2025-12-120.2https://www.astellasanswers.com/us/fezolinetant/post-marketing-and-trial-data-of-hepatic-cases-with-fezolinetant2026-02-230.2https://www.astellasanswers.com/us/fezolinetant/fezolinetant-and-hepatotoxicity-mechanism2026-02-250.2https://www.astellasanswers.com/us/fezolinetant/fezolinetant-and-estrogens2026-03-060.2https://www.astellasanswers.com/us/zolbetuximab/zolbetuximab-extravasation-risk-classification2025-11-040.2https://www.astellasanswers.com/us/zolbetuximab/management-of-zolbetuximab-extravasation2025-11-070.2https://www.astellasanswers.com/us/zolbetuximab/zolbetuximab-temperature-excursion-range2025-11-070.2https://www.astellasanswers.com/us/zolbetuximab/mass-of-zolbetuximab-and-excipients-in-100-mg-vials2025-11-070.2https://www.astellasanswers.com/us/zolbetuximab/mass-of-zolbetuximab-and-excipients-in-300-mg-vials2025-11-070.2https://www.astellasanswers.com/us/zolbetuximab/zolbetuximab-and-observation-period-after-administration2025-11-070.2https://www.astellasanswers.com/us/zolbetuximab/chemotherapy-use-during-the-zolbetuximab-post-infusion-observation-period2025-11-100.2https://www.astellasanswers.com/us/zolbetuximab/zolbetuximab-density-of-reconstituted-solution2025-11-110.2https://www.astellasanswers.com/us/zolbetuximab/information-on-zolbetuximab-and-gleam-trial2025-11-110.2https://www.astellasanswers.com/us/zolbetuximab/zolbetuximab-regulatory-approval2025-12-170.2https://www.astellasanswers.com/us/zolbetuximab/zolbetuximab-treatment-modification-for-nausea2026-01-230.2https://www.astellasanswers.com/us/zolbetuximab/zolbetuximab-treatment-modification-for-vomiting2026-02-020.2https://www.astellasanswers.com/us/zolbetuximab/titration-protocols-for-zolbetuximab-infusion-rate2026-02-020.2https://www.astellasanswers.com/us/zolbetuximab/zolbetuximab-vial-overfill2026-02-180.2https://www.astellasanswers.com/us/zolbetuximab/zolbetuximab-loading-dose-after-missed-doses-or-treatment-interruptions2026-02-190.2https://www.astellasanswers.com/us/zolbetuximab/antiemetic-recommendations-and-usage-in-the-zolbetuximab-phase-3-trials2026-02-250.2https://www.astellasanswers.com/us/zolbetuximab/antiemetic-recommendations-with-zolbetuximab2026-02-260.2https://www.astellasanswers.com/us/zolbetuximab/premedication-recommendations-with-zolbetuximab2026-03-100.2https://www.astellasanswers.com/us/zolbetuximab/information-on-zolbetuximab-use-in-pancreatic-cancer2026-03-190.2https://www.astellasanswers.com/us/zolbetuximab/duration-of-nausea-vomiting-with-zolbetuximab2026-03-260.2https://www.astellasanswers.com/us/zolbetuximab/nausea-and-vomiting-rates-by-treatment-cycle-with-zolbetuximab2026-03-270.2https://www.astellasanswers.com/us/zolbetuximab/zolbetuximab-use-in-2l-and-3l-in-patients-with-advanced-ggej-adenocarcinoma2026-04-010.2https://www.astellasanswers.com/us/avacincaptad-pegol/h2h-comparison-of-acp-and-peg2025-11-110.2https://www.astellasanswers.com/us/avacincaptad-pegol/concomitant-use-of-vitamins-and-minerals-with-acp2025-11-190.2https://www.astellasanswers.com/us/avacincaptad-pegol/prior-history-of-glaucoma2025-11-190.2https://www.astellasanswers.com/us/avacincaptad-pegol/availability-of-prefilled-syringe-acp2025-11-250.2https://www.astellasanswers.com/us/avacincaptad-pegol/gather2-ole-sfr2026-02-050.2https://www.astellasanswers.com/us/avacincaptad-pegol/incidence-of-intraocular-inflammation-in-gather2026-03-020.2https://www.astellasanswers.com/us/avacincaptad-pegol/combination-of-acp-with-anti-vegf-in-ga2026-03-100.2https://www.astellasanswers.com/us/avacincaptad-pegol/acp-and-loss-of-driving-vision2026-03-100.2